Heart benefits of hydroxychloroquine may extend to patients with isolated skin lupus

Early hydroxychloroquine initiation among people with discoid lupus erythematosus — the most common subtype of cutaneous lupus — was associated with lower 5-year risk for cardiometabolic and atherosclerotic outcomes, data show. These complications included hyperlipidemia, peripheral artery disease, angina, coronary artery disease, hypertension, diabetes and stroke, according to the